This federal contract award, valued at $1,335.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a period of performance ending on May 12, 2025. The contract is a firm fixed-price arrangement, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,734.90, is a Firm Fixed Price Delivery Order for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product. The contract has a completion date of March 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,687.64 with a firm fixed price and an ultimate completion date of November 20, 2024. The contract is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,236.68 firm fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2024 and was awarded on July 17, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a $18,547.86 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VISIPAQUE 320 MG/ML medical bottles, with a period of performance through May 8, 2024. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,265.73, is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award, valued at $2,066.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of VISIPAQUE 320 MG/ML infusion bottles, a medical product. The contract has an ultimate completion date of January 15, 2025 and a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $6,523.65, is for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML medical supplies. The contract has a period of performance through February 20, 2024 and is a Firm Fixed Price Delivery Order. This award is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,118.34 firm-fixed-price delivery order is for the supply of VISIPAQUE 320 mg/ml bottles of 100 ml. The award is not associated with a set-aside program. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen, through its Corporate Office division, is a significant supplier of prescription medications, over-the-counter...
This federal contract award, valued at $1,650.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...